Working mechanism of immunoglobulin A1 (IgA1) protease:: Cleavage of IgA1 antibody to Neisseria meningitidis PorA requires de novo synthesis of IgAl protease

被引:19
|
作者
Vidarsson, G
Overbeeke, N
Stemerding, AM
van den Dobbelsteen, G
van Ulsen, P
van der Ley, P
Kilian, M
van de Winkel, JGJ
机构
[1] Univ Med Ctr Utrecht, Dept Immunol, Immunotherapy Lab, NL-3584 EA Utrecht, Netherlands
[2] Netherlands Vaccine Inst, Lab Vaccine Res, Utrecht, Netherlands
[3] Univ Utrecht, Dept Mol Microbiol, Utrecht, Netherlands
[4] Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark
[5] Genmab, Utrecht, Netherlands
关键词
D O I
10.1128/IAI.73.10.6721-6726.2005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neisseria meningitidis secretes a protease that specifically cleaves the hinge region of immunoglobulin At (IgA1), releasing the effector (Fe) domain of IgA1 from the antigen binding (Fab) determinants. Theoretically, the remaining Fab fragments can block pathogen receptors or toxins and still provide protection. Here, we describe binding of V-gene-matched human IgA1 and IgA2 to PorA of strain H44/76. On live meningococci, efficient cleavage of IgA1, but not cleavage of IgA2, was observed, and up to similar to 80% of the IgA1 Fc tails were lost from the meningococcal surface within 30 min. No cleavage of IgA1 was found on an isogenic H44/76 strain lacking IgA1 protease. Furthermore, our data indicate that PorA-bound IgA1 is masked by the serogroup B polysaccharide capsule, rendering the IgA1 less accessible to degradation by secreted IgA1 protease present in the bacterial surroundings. Experiments with protein synthesis inhibitors showed that de novo production of IgA1 protease was responsible for cleavage of PorA-bound IgA1 on encapsulated bacteria. Finally, our data suggest that cleavage of IgA1 by IgA1 protease releases a significant proportion of Fab fragments from the bacterium, probably as a result of their reduced avidity compared to that of whole antibodies.
引用
收藏
页码:6721 / 6726
页数:6
相关论文
共 50 条
  • [41] IgA1 Protease as a Vaccine Basis for Prevention of Bacterial Meningitis
    Zhigis, L. S.
    Kotelnikova, O., V
    Zinchenko, A. A.
    Karlinsky, D. M.
    Prokopenko, Yu A.
    Rumsh, L. D.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2021, 47 (04) : 805 - 814
  • [42] THE SITE OF CLEAVAGE IN HUMAN ALPHA CHAINS OF IGA1 AND IGA2-A2M(1) ALLOTYPE PARAPROTEINS BY THE CLOSTRIDIAL IGA PROTEASE
    FUJIYAMA, Y
    IWAKI, M
    HODOHARA, K
    HOSODA, S
    KOBAYASHI, K
    MOLECULAR IMMUNOLOGY, 1986, 23 (02) : 147 - 150
  • [43] PRELIMINARY-REPORT OF SEPARATE SITES OF IGA1 CLEAVAGE BY THE STREPTOCOCCUS SANGUIS PROTEASE
    BARR, GD
    PRIDDLE, JD
    JEWELL, DP
    CLINICAL SCIENCE, 1984, 66 (02) : P49 - P49
  • [44] IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy
    Lechner, Sebastian M.
    Abbad, Lilia
    Boedec, Erwan
    Papista, Christina
    Le Stang, Marie-Benedicte
    Moal, Christelle
    Maillard, Julien
    Jannin, Agnes
    Bex-Coudrat, Julie
    Wang, Yong
    Li, Aiqun
    Martini, Paolo G. V.
    Monteiro, Renato C.
    Berthelot, Laureline
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (09): : 2622 - 2629
  • [45] The lysosomal/phagosomal membrane protein h-lamp-1 is a target of the IgA1 protease of Neisseria gonorrhoeae
    Hauck, CR
    Meyer, TF
    FEBS LETTERS, 1997, 405 (01) : 86 - 90
  • [46] IgA1 protease from non-typable Haemophilus influenzae cleaves two sites in human IgA1 hinge region
    Mistry, D
    He, S
    Stockley, RA
    THORAX, 2002, 57
  • [47] Cloning, expression, purification, and characterization of Streptococcus pneumoniae IgA1 protease
    Romanello, V
    Marcacci, M
    Dal Molin, F
    Moschioni, M
    Censini, S
    Covacci, A
    Baritussio, AG
    Montecucco, C
    Tonello, F
    PROTEIN EXPRESSION AND PURIFICATION, 2006, 45 (01) : 142 - 149
  • [48] IgA1 protease production by bacteria colonizing the upper respiratory tract
    J. Zakrzewski
    T. Bechert
    J. -P. Guggenbichler
    Infection, 1998, 26 : 116 - 119
  • [49] IgA1 protease production by bacteria colonizing the upper respiratory tract
    Zakrzewski, J
    Bechert, T
    Guggenbichler, JP
    INFECTION, 1998, 26 (02) : 116 - 119
  • [50] Small-Molecule Inhibitors of Haemophilus influenzae IgA1 Protease
    Shehaj, Livia
    Choudary, Santosh K.
    Makwana, Kamlesh M.
    Gallo, Mary C.
    Murphy, Timothy F.
    Kritzer, Joshua A.
    ACS INFECTIOUS DISEASES, 2019, 5 (07): : 1129 - 1138